News

Thiogenesis Therapeutics, Inc. (TSXV: TTI) (OTCQX: TTIPF), a clinical-stage biopharmaceutical company developing next-generation thiol-based therapies for mitochondrial disease and pediatric metabolic ...
Submission Seeks Approval of GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) Comprehensive Data Package ...
The first patient was enrolled at Yale School of Medicine’s Department of Psychiatry, marking a significant milestone in the trial.
This transaction provides a non-dilutive capital infusion of $7 million to Ovid, which will support the Company’s ongoing operations. In 2024, Ovid recorded approximately $566,000 in ganaxolone ...
A bipartisan group of lawmakers on Wednesday vowed to keep Chinese artificial intelligence systems out of federal agencies while pledging to ensure the U.S. will prevail against China in the global ...
New Amendments To Resolution Process Regulations In India. Legal News and Analysis - India - Insolvency & Restructuring - Conventus Law ...
The U.S. Court of Appeals for the Federal Circuit (CAFC) today affirmed a district court’s grant of a motion for judgment on ...
The Federal Circuit affirmed a California district judge’s decision to dismiss a patent suit filed against video conference ...
Apple has escaped a $300 million patent infringement verdict after a three-judge panel of the United States Court of Appeals ...
The team used a modified commercial cryogenic hybrid LNA based on InP HEMTs characterised to demonstrate the feasibility of ...
In this week’s edition of InnovationRx, we look at health insurers' vows to improve prior authorization, Bell Labs’ IP ...